Author:
Graham-Cole Claire L.,Thomas Huw D.,Taylor Gordon A.,Newell David R.,Melton Roger G.,Hesp Richard,Boddy Alan V.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference26 articles.
1. Bagshawe KD, Sharma SK, Springer CJ, Antoniw P (1995) Antibody directed enzyme prodrug therapy (ADEPT): a pilot scale clinical therapy. Tumor Target 1:17–29
2. Blakey D, Davies D, Dowell R, East S, Burke P, Sharma S, Springer C, Mauger A, Melton R (1995) Anti-tumour effects of an antibody-carboxypeptidase G2 conjugate in combination with phenol mustard prodrugs. Br J Cancer 72:1083–1088
3. Blakey DC, Burke PJ, Davies DH, Dowell RI, East SJ, Eckersley KP, Fitton JE, McDaid J, Melton RG, NiculescuDuvaz IA, Pinder PE, Sharma SK, Wright AF, Springer CJ (1996) ZD2767, an improved system for antibody-directed enzyme prodrug therapy that results in tumor regressions in colorectal tumor xenografts. Cancer Res 56(14):3287–3292
4. Fox SB, Engels K, Comley M, Whitehouse RM, Turley H, Gatter KC, Harris AL (1997) Relationship of elevated tumour thymidine phosphorylase in node-positive breast carcinomas to the effects of adjuvant CMF. Ann Oncol 8(3):271–275
5. Iltzsch M, Kouni ME, Cha S (1985) Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry 24:2871–2875
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献